These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9059686)
1. Chemotherapy-induced acral erythema due to Tegafur. Bastida J; Díaz-Cascajo C; Borghi S Acta Derm Venereol; 1997 Jan; 77(1):72-3. PubMed ID: 9059686 [No Abstract] [Full Text] [Related]
2. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur. Rios-Buceta L; Buezo GF; Peñas PF; Dauden E; Fernandez-Herrera J; Garcia-Diez A Acta Derm Venereol; 1997 Jan; 77(1):80-1. PubMed ID: 9059693 [No Abstract] [Full Text] [Related]
3. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur. Jucglà A; Sais G; Navarro M; Peyri J Arch Dermatol; 1995 Mar; 131(3):364-5. PubMed ID: 7887678 [No Abstract] [Full Text] [Related]
4. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1). Park YJ; Soh BW; Lee ES Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899 [No Abstract] [Full Text] [Related]
5. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia. Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263 [TBL] [Abstract][Full Text] [Related]
6. A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter. Ciccolini J; Evrard A; Lacarelle B Clin Cancer Res; 2012 Jan; 18(1):317. PubMed ID: 22215908 [No Abstract] [Full Text] [Related]